Occult and Overt HBV Co-Infections Independently Predict Postoperative Prognosis in HCV-Associated Hepatocellular Carcinoma

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Chang, Ming Ling ^a,b   Lin, Yu Jr ^a   Chang, Chee Jen ^a   Yeh, Charisse ^c   Chen, Tse Ching ^a   Yeh, Ta Sen ^a   Lee, Wei Chen ^a   Yeh, Chau Ting ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c Flintridge Sacred Heart Academy La Canada Flintridge   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; BILIRUBIN; HEPATITIS B SURFACE ANTIGEN; SERUM ALBUMIN; VIRUS DNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CANCER PROGNOSIS; CANCER SIZE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NONHUMAN; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PREDICTION; TAIWAN; VIRUS GENOME; VIRUS MUTATION; AGED; CARCINOMA, HEPATOCELLULAR; CLINICAL TRIAL; COINFECTION; HEPACIVIRUS; HEPATITIS B VIRUS; HEPATITIS C; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; PATHOLOGY; PREDICTIVE VALUE; RETROSPECTIVE STUDY; SURVIVAL RATE;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

AGED; CARCINOMA, HEPATOCELLULAR; COINFECTION; DISEASE-FREE SURVIVAL; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84879262261     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064891     Document Type: Article

References (39)

1. Talwalkar JA, Gores GJ, (2004) Diagnosis and staging of hepatocellular carcinoma. Gastroenterology127: S126-32.
2. Yang JD, Roberts LR, (2010) Hepatocellular carcinoma: A global view. Nat Rev Gastroenterol Hepatol. 7: 448-58.
3. Kensler TW, Egner PA, Wang JB, Zhu YR, Zhang BC, et al Chemoprevention of hepatocellular carcinoma in aflatoxin endemic areas. Gastroenterology 127: S310-S318.
4. El-Serag HB, (2012) Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology142: 1264-1273.
5. Taylor-Robinson SD, Foster GR, Arora S, Hargreaves S, Thomas HC, (1997) Increase in primary liver cancer in the UK, 1979-94. Lancet 350: 1142-1143.
6. Lai MY, (2006) Combined interferon and ribavirin therapy for chronic hepatitis C in Taiwan. Intervirology 49: 91-5.
7. Obika M, Shinji T, Fujioka S, Terada R, Ryuko H, et al. (2008) Hepatitis B virus DNA in liver tissue and risk for hepatocarcinogenesis in patients with hepatitis C virus-related chronic liver disease. A prospective study. Intervirology 51: 59-68.
8. Torbenson M, Thomas DL, (2002) Occult hepatitis B. Lancet Infect Dis. 2: 479-86.
9. Pollicino T, Raffa G, Costantino L, Lisa A, Campello C, et al. (2007) Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma. Hepatology 45: 277-85.
10. Bellecave P, Gouttenoire J, Gajer M, Brass V, Koutsoudakis G, et al. (2009) Hepatitis B and C virus coinfection: a novel model system reveals the absence of direct viral interference. Hepatology 50: 46-55.
11. Eyre NS, Phillips RJ, Bowden S, Yip E, Dewar B, et al. (2009) Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells. J Hepatol 51: 446-57.
12. Chisari FV, (2000) Viruses, immunity, and cancer lessons from hepatitis B. Am J Pathol. 156: 1118-1132.
13. Yotsuyanagi H, Yasuda K, Iino S, Moriya K, Shintani Y, et al. (1998) Persistent viremia after recovery from self-limited acute hepatitis B. Hepatology. 27: 1377-1382.
14. Raimondo G, (2001) Occult hepatitis B virus infection and liver disease: Fact or fiction? J Hepatol 34: 471-473.
15. Bouchard MJ, Navas-Martin S, (2011) Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges. Cancer Lett. 305: 123-43.
16. Jardi R, Rodriguez F, Buti M, Costa X, Cotrina M, et al. (2001) Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference. Hepatology 34: 404-10.
17. Donato F, Boffetta P, Puoti M, (1998) A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 75: 347-354.
18. Cho LY, Yang JJ, Ko KP, Park B, Shin A, et al. (2011) Coinfection of hepatitis B and C viruses and risk of hepatocellular carcinoma: systematic review and meta-analysis. Int J Cancer. 128: 176-84.
19. Pollicino T, Squadrito G, Cerenzia G, Cacciola I, Raffa G, et al. (2004) Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology 126: 102-110.
20. Lok AS, Everhart JE, Di Bisceglie AM, Kim HY, Hussain M, et al. (2011) Occult and previous hepatitis B virus infection are not associated with hepatocellular carcinoma in United States patients with chronic hepatitis C. Hepatology. 54: 434-42.
21. Lee MH, Yang HI, Lu SN, Jen CL, Yeh SH, et al. (2010) Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study. J Clin Oncol 28: 4587-93.
22. Yeh CT, So M, Ng J, Yang HW, Chang ML, et al. (2010) Hepatitis B virus-DNA level and basal core promoter A1762T/G1764A mutation in liver tissue independently predict postoperative survival in hepatocellular carcinoma. Hepatology 52: 1922-33.
23. Guo H, Jiang D, Zhou T, Cuconati A, Block TM, et al. (2007) Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation. J Virol. 81: 12472-84.
24. El Chaar M, Candotti D, Crowther RA, Allain JP, (2010) Impact of hepatitis B virus surface protein mutations on the diagnosis of occult hepatitis B virus infection. Hepatology. 52: 1600-10.
25. Murakami Y, Saigo K, Takashima H, Minami M, Okanoue T, et al. (2005) Large scaled analysis of HBV DNA integration in HBV related hepatocellular carcinomas. Gut 54: 1162-8.
26. Yeh CT, Chen TC, Shyu WC, Chien, et al (1997) Quantitative assessment of serum hepatitis b virus DNA: comparison between two different methods. Hepatology Res 7: 159-164.
27. Chu CM, Yeh CT, Chien RN, Sheen IS, Liaw YF, (1997) The degrees of hepatocyte nuclear but not cytoplasmic expression of hepatitis B core antigen reflect the level of viral replication in chronic hepatitis B virus infection. J Clin Microbiol. 35: 102-5.
28. Chen CJ, Wang LY, Yu MW, (2000) Epidemiology of hepatitis B virus infection in the Asia-Pacific region. J Gastroenterol Hepatol 15: E3-E6.
29. Hsu HY, Chang MH, Chen DS, Lee CY, Sung JL, (1986) Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: A study just before mass hepatitis B vaccination program in Taiwan. J Med Virol 18: 301-307.
30. Lu SN, Chen HC, Tang CM, Wu MH, Yu ML, et al. (1998) Prevalence and manifestations of hepatitis C seropositivity in children in an endemic area. Pediatr Infect Dis J 17: 142-145.
31. Kaklamani E, Trichopoulos D, Tzonou A, Zavitsanos X, Koumantaki Y, et al. (1991) Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. JAMA 265: 1974-1976.
32. Matsuzaki Y, Chiba T, Hadama T, Asaoka H, Doy M, et al. (1997) HBV genome integration and genetic instability in HBsAg-negative and anti-HCV-positive hepatocellular carcinoma in Japan. Cancer Lett 119: 53-61.
33. Yamamoto K, Horikita M, Tsuda F, Itoh K, Akahane Y, et al. (1994) Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. J Virol 68: 2671-6.
34. Liu CJ, Chen BF, Chen PJ, Lai MY, Huang WL, et al. (2006) Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers. J Infect Dis 193: 1258-65.
35. Yang HI, Yeh SH, Chen PJ, Iloeje UH, Jen CL, et al. (2008) Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J Natl Cancer Inst 100: 1134-43.
36. Fujiwara Y, Shiba H, Furukawa K, Iida T, Haruki K, et al. (2010) Glasgow prognostic score is related to blood transfusion requirements and post-operative complications in hepatic resection for hepatocellular carcinoma. Anticancer Res. 30: 5129-36.
37. Ryu SH, Chung YH, Lee H, Kim JA, Shin HD, et al. (2008) Metastatic tumor antigen 1 is closely associated with frequent postoperative recurrence and poor survival in patients with hepatocellular carcinoma. Hepatology 47: 929-36.
38. Bréchot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, et al. (2001) Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? Hepatol 34: 194-203.
39. Liaw YF, (1995) Role of hepatitis C virus in dual and triple hepatitis virus infection. Hepatology 22: 1101-1108.